February 13, 2018 / 9:21 AM / 2 months ago

BRIEF-Staidson Beijing BioPharmaceuticals unit to invest in Beijing-based firm and limited partnership

Feb 13(Reuters) - Staidson Beijing BioPharmaceuticals Co Ltd

* Says co’s Zhejiang-based wholly owned investment unit plans to invest 30 million yuan in Beijing-based medical science and technology development firm (target firm)

* Says unit will hold 5 percent stake in target firm

* Says unit plans to invest 35.5 million yuan in a limited partnership for portion worth 7.8 million yuan

Source text in Chinese: goo.gl/aFWS6W; goo.gl/ArVSG1

Further company coverage: (Beijing Headline News)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below